Biogen Inc. buy Haans
Start price
24.10.16
/
50%
€261.98
Target price
24.04.17
€288.64
Performance (%)
3.34%
End price
24.04.17
€250.39
Summary
This prediction ended on 24.04.17 with a price of €250.39. With a performance of 3.34%, the BUY prediction by Haans for Biogen Inc. closed with a slight gain. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 3.951% | 3.951% | 57.648% | -23.602% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Biotech muss man nicht haben, aber man sollte...
Das Aufwärtsgap , von Ende Juli, wurde geschlossen, jetzt kann es wieder Richtung Norden gehen.
(Laufzeit überschritten)